UK sets first safety guidance for precision fermentation foods as regulators move to support next generation of biotech ingredients

The UK has taken a significant step toward regulating next-generation food technologies with the publication of the country’s first safety guidance covering precision fermentation products.

The guidance, issued by the Food Standards Agency (FSA) in partnership with Food Standards Scotland (FSS), sets out how foods and ingredients produced using precision fermentation should be assessed under existing food safety frameworks. It also outlines the scientific evidence companies will need to demonstrate that these products are safe for consumers.

The move forms part of a broader effort by UK regulators to prepare for the rapid emergence of biotechnology-driven food ingredients, including proteins, fats, vitamins and other compounds produced by engineered microorganisms.

• The UK’s Food Standards Agency and Food Standards Scotland have issued the country’s first safety guidance for foods produced using precision fermentation.
• The framework clarifies how products should be classified under existing hygiene regulations and what evidence companies must provide during safety assessments.
• Expert workshops have also identified key hazard evaluation methods, including DNA analysis, allergenicity testing and digestibility studies.

Precision fermentation refers to a specialized form of microbial fermentation in which microorganisms such as bacteria or yeast are cultivated in controlled environments to produce specific molecules. These can include proteins, lipids, carbohydrates and vitamins that are later extracted and purified for use in food products.

Unlike traditional fermentation processes that generate a mixture of metabolic compounds, precision fermentation uses advanced biotechnology to program microorganisms to produce targeted ingredients with a high degree of purity and consistency.

Following fermentation, the desired compound is separated from the fermentation broth and purified before being incorporated into food. The process is designed to ensure that no live production organisms remain in the final product.

According to the FSA and FSS, foods made using precision fermentation may include a wide range of ingredients, from functional proteins used in dairy alternatives to specialized nutrients and fats incorporated into processed foods.

The newly released guidance aims to help businesses understand how existing hygiene legislation applies to these products and clarify the responsibilities of food business operators involved in their production.

Although the guidance does not introduce new law, it provides interpretation of existing regulations and explains how companies can demonstrate compliance.

“This guidance has been developed using a robust, science-based framework,” the agencies noted, adding that the approach is intended to give companies earlier clarity about regulatory expectations while supporting innovation in emerging food technologies.

The document was developed through the FSA and FSS Innovation Research Programme, funded by the UK Department for Science, Innovation and Technology.

Officials said the initiative aims to support responsible growth in food innovation by ensuring that safety assessment processes keep pace with technological advances.

A central element of the guidance is the classification of precision fermentation products under existing food hygiene regulations.

Under the agencies’ current interpretation, products produced through precision fermentation may be classified as Products of Animal Origin if animal-derived cells, tissues or materials are used at any stage of the production process.

For example, if microorganisms are programmed using genetic material obtained from animal cells, the resulting ingredient may fall under the regulatory framework governing animal-origin products.

However, if the genetic instructions used to engineer microorganisms are sourced digitally from public genetic databases and the DNA used in production is synthesized rather than extracted from animals, the ingredient would not be considered to originate from animal sources for the purposes of those specific hygiene rules.

The guidance emphasized that this classification applies only to the hygiene regulations covered under Regulation (EC) 853/2004 and does not automatically determine how the product will be treated under other areas of food law.

Regulators also noted that the guidance reflects the agencies’ current interpretation of existing legislation and may evolve as new technologies emerge.

Alongside the regulatory guidance, the agencies have also published findings from a series of expert workshops examining the technical production methods of precision fermented foods and the potential hazards associated with these processes.

The meetings brought together scientists and regulatory specialists to identify practical approaches for evaluating safety during novel food assessments.

The workshops focused on several areas that frequently present challenges for applicants, including bioinformatics analysis of genetic sequences, laboratory digestion tests used to evaluate protein quality and allergenicity, and a case study involving a precision fermented version of beta-lactoglobulin, a major milk protein.

Experts concluded that the most important hazards to assess depend on how the fermentation product is manufactured.

For products in which microorganisms are engineered to produce purified ingredients, safety assessments should focus on whether any potentially harmful residues remain after manufacturing and purification.

These may include traces that could trigger allergic reactions, toxins produced by microorganisms or genes associated with antibiotic resistance.

In cases where the microbial organism itself is intended to be consumed as food, experts emphasized the importance of correctly identifying the species and demonstrating that the production process renders the organism safe for consumption.

Whole genome sequencing was identified as the most reliable method for confirming microbial identity and detecting genetic features that might indicate potential hazards.

However, specialists stressed that computational analysis alone is not sufficient.

Bioinformatics tools can identify possible concerns in genetic data, but laboratory testing is needed to confirm whether these features are present in the final ingredient.

Another key area discussed during the workshops was the evaluation of digestibility and allergenicity.

Experts agreed that laboratory digestion assays are particularly important when a precision fermentation ingredient is intended to contribute meaningfully to dietary protein intake, such as in dairy, egg or meat alternatives.

Where the ingredient is used only in small quantities for technical purposes, such testing may not be necessary.

The workshops also examined how processing methods can influence allergenicity and protein stability.

Proteins that remain intact during digestion may present greater allergy risks, while those that break down quickly are generally considered less problematic.

The beta-lactoglobulin case study provided a practical example of how regulators might evaluate allergenicity, nutritional value and safety data together during the assessment process.

Beyond molecular and genetic analysis, experts highlighted the importance of validating manufacturing controls.

Production processes should include clear evidence that microbial cultures are effectively inactivated during processing, including documentation of starting microbial levels, time and temperature conditions and measurable reductions across multiple production batches.

Shelf-life claims should also be supported by robust studies demonstrating how safety, nutritional value and functional properties change over time.

Regulators said the findings from the expert discussions will help create a clearer and more predictable pathway for companies submitting applications for precision fermentation products.

Assessors at the FSA and FSS are expected to incorporate the lessons from the workshops into future guidance documents that will inform novel food applications.

The agencies said the overall aim is to reduce uncertainty for companies developing precision fermentation technologies while maintaining strong consumer protection standards.

By clarifying what constitutes appropriate evidence and how safety data will be evaluated, regulators hope to reduce the number of follow-up questions during the approval process and shorten review timelines.

The guidance reflects a broader shift among food regulators toward preparing regulatory systems for emerging biotechnology-driven food production.

Precision fermentation is increasingly being explored by companies seeking to produce dairy proteins, egg proteins, fats and other ingredients without relying on conventional agriculture.

As investment in these technologies continues to grow, regulators are under increasing pressure to ensure that safety assessment frameworks are equipped to evaluate novel production methods.

By outlining the scientific evidence required to support safety and nutritional adequacy, the UK’s new guidance represents one of the first attempts to provide a comprehensive regulatory framework specifically tailored to precision fermentation products.

Officials said the flexible, evidence-based approach is designed to evolve alongside the technology itself, allowing regulators to maintain consumer safety while supporting innovation in the rapidly developing field of food biotechnology.